Literature DB >> 34271501

Copper exposure induces hepatic G0/G1 cell-cycle arrest through suppressing the Ras/PI3K/Akt signaling pathway in mice.

Huan Liu1, Huidan Deng2, Zhijie Jian1, Hengmin Cui3, Hongrui Guo4, Jing Fang2, Zhicai Zuo2, Junliang Deng2, Yinglun Li2, Xun Wang2, Ling Zhao2, Yanqiu Zhu1.   

Abstract

Copper (Cu), as a common chemical contaminant in environment, is known to be toxic at high concentrations. The current research demonstrates the effects of copper upon hepatocyte cell-cycle progression (CCP) in mice. Institute of cancer research (ICR) mice (n = 240) at an age of four weeks were divided randomly into groups treated with different doses of Cu (0, 4, 8, and 16 mg/kg) for 21 and 42 days. Results showed that high Cu exposure caused hepatocellular G0/G1 cell-cycle arrest (CCA) and reduced cell proportion in the G2/M phase. G0/G1 CCA occurred with down-regulation (p < 0.05) of Ras, p-PI3K (Tyr458), p-Akt (Thr308), p-forkhead box O3 (FOXO3A) (Ser253), p-glycogen synthase kinase 3-β (GSK3-β) (Ser9), murine double minute 2 (MDM2) protein, and mRNA expression levels, and up-regulation (p < 0.05) of PTEN, p-p53 (Ser15), p27, p21 protein, and mRNA expression levels, which subsequently suppressed (p < 0.05) the protein and mRNA expression levels of CDK2/4 and cyclin E/D. These results indicate that Cu exposure suppresses the Ras/PI3K/Akt signaling pathway to reduce the level of CDK2/4 and cyclin E/D, which are essential for the G1-S transition, and finally causes hepatocytes G0/G1 CCA.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Copper; G0/G1 cell-cycle arrest; Liver; Ras/PI3K/Akt signaling pathway

Year:  2021        PMID: 34271501     DOI: 10.1016/j.ecoenv.2021.112518

Source DB:  PubMed          Journal:  Ecotoxicol Environ Saf        ISSN: 0147-6513            Impact factor:   6.291


  1 in total

1.  Carbohydrate Metabolism Parameters of Adult Glial Neoplasms According to Immunohistochemical Profile.

Authors:  Larisa Obukhova; Olga Nikiforova; Claudia Kontorshchikova; Igor Medyanik; Natalya Orlinskaya; Artem Grishin; Michael Kontorshchikov; Natalya Shchelchkova
Journal:  Biomedicines       Date:  2022-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.